Hathaway Pease Russell
Hathaway Pease Russell practices intellectual property law with a focus on the life sciences industry. She has extensive experience assisting research institutions, start-up biotechnology companies, and established U.S. and international corporations with many aspects of intellectual property law, including patent portfolio management, freedom-to-operate analysis, due diligence, complex patent litigation and interference proceedings.
Hathaway has a particular interest in the areas of pharmacogenomics, proteomics and disease biomarkers, and their application to personalized medicine. She collaborates with the firm's Government Strategies Group on regulatory matters, including recent initiatives by the FDA in the area of advanced diagnostics, and also works with the Litigation Group, for which she recently filed an amicus brief in the U.S. Supreme Court on behalf of the Association of University Technology Managers in Mayo Collaborative Services and Mayo Clinic Rochester v. Prometheus Laboratories, Inc.
In addition to her practice, Hathaway has lectured on patenting strategies and in vitro diagnostics at national and international conferences. She is an active member of the American Intellectual Property Law Association (AIPLA) and serves as the current Vice-Chair of the Women in IP Committee. Hathaway also co-organizes the Consumer Genetics Conference, an annual conference that covers the intellectual property, regulatory and policy landscapes in the field of personalized medicine.
Bars and Court Admissions
- Texas
- Massachusetts
- U.S. Patent & Trademark Office (Agency)
professional / civic involvement
- American Intellectual Property Law Association (AIPLA)
- Vice-Chair Women in IP Committee, October 2011-present
- Vice-Chair Education Committee, October 2009-October 2011
- Chair Women's National Networking Event, October 2009-October 2011
- Chair of Subcommittee of Legislative Policy for Biotechnology Committee
- Pro Bono matters for Boston Housing Authority
- Participates as a coach for VC 101 for Center for Women & Enterprise, March 2008
- Former Co-leader Boston Young Lawyer’s Committee
- Boston Patent Law Association, Member
- American Bar Association, Member
SPEECHES AND CONFERENCES
- Speaker, “Personalized Medicine: Intellectual Property Protection, FDA Regulation and Reimbursement,” AUTM 2012, March 2012
- Speaker, “Diagnostics - The Changing IP and Regulator Landscape,” G2 Intelligence’s Molecular Diagnostics Conference, April 2011
- Moderator, "Genetics in the Regulatory & Policy Realm," 3rd Annual Consumer Genetics Conference, June 2011
- Moderator, "Using the Internet For Litigation and Prosecution in the New Information Age," February 2011
- Contributor, Roundtable Discussion: Talking About Gene Patents With the Public, February 2011
- Co-Host, Teaching Children About Patent Law and Innovation, February 2011
- Presenter, "Understanding the Implications of the Rapidly Evolving U.S. Healthcare and Regulatory Environment," AusBiotech 2010, October 2010
- Moderator, "Maintaining and Gaining Career, Momentum in Spite of the Economic Downturn," American Intellectual Property Law Association, January 2010
- Co-Organizer, Consumer Genetics Conference, June 2010
- "Overview of the Requirements for Patentability," AIPLA Boot Camp: 2008 Practical Patent Prosecution Training for New Lawyers, August 2009 and August 2008
- Co-Organizer, First Annual Consumer Genetics Conference, June 2009
- Moderator, "Making Sense of the Data and Explaining It to the Consumer," Consumer Genetics Conference, June 2009
- Moderator, "Genetics and the Law: Intellectual Property, Regulation and Public Policy," Consumer Genetics Conference, June 2009
- Presenter, "Protecting Your Business," June 2009
- Presenter, "Utility Issues In Biotechnology, Chemical and Pharmaceutical Patents," New York Intellectual Property Association, April, 2001
publications
- Drafted AIPLA comments on behalf of the Biotechnology Committee on proposed rules of practice pertaining to "Revision to the Time for Filing of a Biological Deposit and the Date of Availability of a Biological Deposit," April 2008
- Assisted in drafting accepted application entitled "A Case Study of a Biotechnology-Related Action Before the International Trade Commission" for BIO 2008
- Drafted AIPLA comments on behalf of the Biotechnology Committee on the proposed rules of practice pertaining to claims using alternative language, October 15, 2007